I don't understand the fixation on new MRI licenses. Revenue for the 6 months to Dec 31 2017 was $56 Million. Revenue for the 6 months to June 30 2018 was $64 Million. The Melbourne/Perth acquisitions completed end September should add $4 Million. Assuming a stable business state revenue for this 6 months should be $70 Million. At 19% margin the increase in EBITDA should be $3 Million. My pcp comparisons are Revenue increase of 25% and EBIT increase of 60%.
btw In the June accounts Management impaired the whole value of the Enlitic investment which produced the loss for the year. In the AGM Pres Management allude to the possibility of revaluing Enlitic in the December half.
...or am I missing something?
CAJ, page-38
-
- There are more pages in this discussion • 130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $300.3K | 811.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 135323 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 1208 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |
